Daumer M - Search Results

1

Prognosis of the individual course of disease: the elements of time, heterogeneity and precision.

Daumer M, Neuhaus A, Herbert J, Ebers G. Daumer M, et al. J Neurol Sci. 2009 Dec;287 Suppl 1:S50-5. doi: 10.1016/S0022-510X(09)71301-2. J Neurol Sci. 2009. PMID: 20106349

2

Fampridine and real-life walking in multiple sclerosis: Low predictive value of clinical test for habitual short-term changes.

Stellmann JP, Jlussi M, Neuhaus A, Lederer C, Daumer M, Heesen C. Stellmann JP, et al. Among authors: daumer m. J Neurol Sci. 2016 Sep 15;368:318-25. doi: 10.1016/j.jns.2016.07.051. Epub 2016 Jul 25. J Neurol Sci. 2016. PMID: 27538657

3

Prognosis of the individual course of disease--steps in developing a decision support tool for Multiple Sclerosis.

Daumer M, Neuhaus A, Lederer C, Scholz M, Wolinsky JS, Heiderhoff M; Sylvia Lawry Centre for Multiple Sclerosis Research. Daumer M, et al. BMC Med Inform Decis Mak. 2007 May 8;7:11. doi: 10.1186/1472-6947-7-11. BMC Med Inform Decis Mak. 2007. PMID: 17488517 Free PMC article.

4

MRI as an outcome in multiple sclerosis clinical trials.

Daumer M, Neuhaus A, Morrissey S, Hintzen R, Ebers GC. Daumer M, et al. Neurology. 2009 Feb 24;72(8):705-11. doi: 10.1212/01.wnl.0000336916.38629.43. Epub 2008 Dec 10. Neurology. 2009. PMID: 19073945

5

Reducing the probability of false positive research findings by pre-publication validation - experience with a large multiple sclerosis database.

Daumer M, Held U, Ickstadt K, Heinz M, Schach S, Ebers G. Daumer M, et al. BMC Med Res Methodol. 2008 Apr 10;8:18. doi: 10.1186/1471-2288-8-18. BMC Med Res Methodol. 2008. PMID: 18402689 Free PMC article.

6

Early relapses, onset of progression, and late outcome in multiple sclerosis.

Scalfari A, Neuhaus A, Daumer M, Deluca GC, Muraro PA, Ebers GC. Scalfari A, et al. Among authors: daumer m. JAMA Neurol. 2013 Feb;70(2):214-22. doi: 10.1001/jamaneurol.2013.599. JAMA Neurol. 2013. PMID: 23407713

7

Onset of secondary progressive phase and long-term evolution of multiple sclerosis.

Scalfari A, Neuhaus A, Daumer M, Muraro PA, Ebers GC. Scalfari A, et al. Among authors: daumer m. J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):67-75. doi: 10.1136/jnnp-2012-304333. Epub 2013 Mar 13. J Neurol Neurosurg Psychiatry. 2014. PMID: 23486991

8

Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review.

Stellmann JP, Neuhaus A, Lederer C, Daumer M, Heesen C. Stellmann JP, et al. Among authors: daumer m. PLoS One. 2014 Mar 20;9(3):e92761. doi: 10.1371/journal.pone.0092761. eCollection 2014. PLoS One. 2014. PMID: 24651401 Free PMC article.

9

Ecological validity of walking capacity tests in multiple sclerosis.

Stellmann JP, Neuhaus A, Götze N, Briken S, Lederer C, Schimpl M, Heesen C, Daumer M. Stellmann JP, et al. Among authors: daumer m. PLoS One. 2015 Apr 16;10(4):e0123822. doi: 10.1371/journal.pone.0123822. eCollection 2015. PLoS One. 2015. PMID: 25879750 Free PMC article.

10

The relationship of age with the clinical phenotype in multiple sclerosis.

Scalfari A, Lederer C, Daumer M, Nicholas R, Ebers GC, Muraro PA. Scalfari A, et al. Among authors: daumer m. Mult Scler. 2016 Nov;22(13):1750-1758. doi: 10.1177/1352458516630396. Epub 2016 Feb 11. Mult Scler. 2016. PMID: 26869531

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

171 results

Search Page

Filters